Whitehawk Therapeutics GAAP EPS of -$0.26 misses by $0.33
Source: SeekingAlpha
2025-11-06 08:28:36 ET
More on Whitehawk Therapeutics
- Whitehawk Therapeutics, Inc. (WHWK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- Tempus partners with Whitehawk Therapeutics to advance cancer research
- Seeking Alpha’s Quant Rating on Whitehawk Therapeutics
- Historical earnings data for Whitehawk Therapeutics
- Financial information for Whitehawk Therapeutics
Read the full article on Seeking Alpha
For further details see:
Whitehawk Therapeutics GAAP EPS of -$0.26 misses by $0.33
Whitehawk Therapeutics Inc.
NASDAQ: WHWK
WHWK Trading
1.91% G/L:
$4.18 Last:
137,878 Volume:
$4.08 Open:
WHWK Latest News
February 18, 2026 08:00:00 am
Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
January 08, 2026 08:00:00 am
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016
December 01, 2025 08:00:00 am
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer
November 26, 2025 08:00:00 am
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
WHWK Stock Data
$132,430,697
23,611,309
1.38%
15
N/A
Biotechnology & Life Sciences
Healthcare
US
Morristown
